KEGG   DRUG: Recombinant adsorbed quadrivalent human papillomavirus virus-like particle vaccine (yeast origin)
Entry
D10192                      Drug                                   
Name
Recombinant adsorbed quadrivalent human papillomavirus virus-like particle vaccine (yeast origin);
Gardasil (TN);
Silgard (TN)
Product
GARDASIL (Merck Sharp & Dohme LLC)
Remark
Therapeutic category: 6313
ATC code: J07BM01
Product: D10192<JP/US>
Efficacy
Active immunization (papillomavirus)
  Disease
Cervical cancer [DS:H00030]
Vulvar cancer [DS:H00029]
Genital warts; Condyloma acuminata [DS:H01418]
Anal cancer [DS:H00044]
Interaction
Structure map
map07044  Antiviral agents
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J07 VACCINES
   J07B VIRAL VACCINES
    J07BM Papillomavirus vaccines
     J07BM01 Papillomavirus (human types 6, 11, 16, 18)
      D10192  Recombinant adsorbed quadrivalent human papillomavirus virus-like particle vaccine (yeast origin) <JP/US>
USP drug classification [BR:br08302]
 Immunological Agents
  Vaccines
   Human Papillomavirus (HPV)
    Human Papillomavirus Quadrivalent (types 6, 11, 16 and 18) Vaccine Recombinant
     D10192  Recombinant adsorbed quadrivalent human papillomavirus virus-like particle vaccine (yeast origin)
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   631  Vaccines
    6313  Viral vaccines
     D10192  Recombinant adsorbed quadrivalent human papillomavirus virus-like particle vaccine (yeast origin)
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10192
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D10192
Other DBs
PubChem: 135626910
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system